535 related articles for article (PubMed ID: 26160839)
21. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
Parajuli P; Tiwari RV; Sylvester PW
Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
[TBL] [Abstract][Full Text] [Related]
22. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
[TBL] [Abstract][Full Text] [Related]
23. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
[TBL] [Abstract][Full Text] [Related]
24. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
25. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
Finlay DK
Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
[TBL] [Abstract][Full Text] [Related]
26. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
[TBL] [Abstract][Full Text] [Related]
27. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
[TBL] [Abstract][Full Text] [Related]
28. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
[TBL] [Abstract][Full Text] [Related]
29. Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections.
Krakauer T
Med Hypotheses; 2015 Dec; 85(6):997-1001. PubMed ID: 26384528
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
31. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
32. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
[TBL] [Abstract][Full Text] [Related]
33. Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
Huang Y; Zhou J; Luo S; Wang Y; He J; Luo P; Chen Z; Liu T; Tan X; Ou J; Miao H; Liang H; Shi C
Gut; 2018 Feb; 67(2):307-319. PubMed ID: 27849558
[TBL] [Abstract][Full Text] [Related]
34. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
[TBL] [Abstract][Full Text] [Related]
35. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway.
Long WB; Pu X; Tang Y; Li M; Liu Y; She Q; Wang YL; Guo QX
Curr Med Sci; 2022 Aug; 42(4):733-741. PubMed ID: 35798928
[TBL] [Abstract][Full Text] [Related]
36. SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway.
Jing Z; Sui X; Yao J; Xie J; Jiang L; Zhou Y; Pan H; Han W
Cancer Lett; 2016 Mar; 372(2):226-38. PubMed ID: 26803057
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
38. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
39. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression.
Weng ML; Chen WK; Chen XY; Lu H; Sun ZR; Yu Q; Sun PF; Xu YJ; Zhu MM; Jiang N; Zhang J; Zhang JP; Song YL; Ma D; Zhang XP; Miao CH
Nat Commun; 2020 Apr; 11(1):1869. PubMed ID: 32313017
[TBL] [Abstract][Full Text] [Related]
40. A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis.
Hussain A; Qazi AK; Mupparapu N; Kumar A; Mintoo MJ; Mahajan G; Sharma PR; Singh SK; Bharate SB; Zargar MA; Ahmed QN; Mondhe DM; Vishwakarma RA; Hamid A
Mol Carcinog; 2016 Dec; 55(12):2135-2155. PubMed ID: 26764221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
